Bowel Preparation for Colonoscopy Among Individuals With IBD: A Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

The purpose of this study is to compare how effective and how tolerable two different bowel preparation laxatives are for colonoscopy. The aim is to compare oral sulfate solution (OSS) to another laxative called 2L polyethylene glycol (PEG) solution to see which is more effective and more tolerable by individuals with IBD (Crohn's disease or Ulcerative colitis).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Crohn's disease or ulcerative colitis patients scheduled or about to be scheduled for colonoscopy.

• Age \> 18 years

• Out-patients

Locations
Other Locations
Canada
University of Manitoba
RECRUITING
Winnipeg
Contact Information
Primary
Jane Castelli
jcast@mcmaster.ca
289-880-3609
Time Frame
Start Date: 2024-07-04
Estimated Completion Date: 2026-05
Participants
Target number of participants: 418
Treatments
Active_comparator: OSS
Active_comparator: 2L PEG
Sponsors
Collaborators: Canadian IBD Research Consortium (CIRC)
Leads: University of Manitoba

This content was sourced from clinicaltrials.gov

Similar Clinical Trials